BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 33170478)

  • 1. Distinctive Clinical Characteristics and Outcome of ILD-Onset Rheumatoid Arthritis and ACPA-Positive ILD: a Longitudinal Cohort of 282 Cases.
    Chen RX; Zhao LD; Xiao XY; Song L; Du HY; Xu ZJ; Feng RE; Yang HX; Fei YY; Zhang W; Zhang FC; Chen H; Zhang X
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):46-54. PubMed ID: 33170478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis.
    Xie S; Li S; Chen B; Zhu Q; Xu L; Li F
    Clin Rheumatol; 2021 Nov; 40(11):4533-4543. PubMed ID: 34189672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with interstitial lung disease in patients with rheumatoid arthritis: A systematic review and meta-analysis.
    Zhang M; Yin J; Zhang X
    PLoS One; 2023; 18(6):e0286191. PubMed ID: 37352174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.
    Oka S; Higuchi T; Furukawa H; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S
    BMC Musculoskelet Disord; 2022 Jan; 23(1):46. PubMed ID: 35027028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
    Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
    Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. Veterans.
    Natalini JG; Baker JF; Singh N; Mahajan TD; Roul P; Thiele GM; Sauer BC; Johnson CR; Kawut SM; Mikuls TR; England BR
    Ann Am Thorac Soc; 2021 Apr; 18(4):598-605. PubMed ID: 33026891
    [No Abstract]   [Full Text] [Related]  

  • 7. High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
    Tyker A; Ventura IB; Lee CT; Strykowski R; Garcia N; Guzy R; Jablonski R; Vij R; Strek ME; Chung JH; Adegunsoye A
    Sci Rep; 2021 Nov; 11(1):22821. PubMed ID: 34819525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.
    Giles JT; Danoff SK; Sokolove J; Wagner CA; Winchester R; Pappas DA; Siegelman S; Connors G; Robinson WH; Bathon JM
    Ann Rheum Dis; 2014 Aug; 73(8):1487-94. PubMed ID: 23716070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis.
    Zaccardelli A; Liu X; Ford JA; Cui J; Lu B; Chu SH; Schur PH; Speyer CB; Costenbader KH; Robinson WH; Sokolove J; Karlson EW; Camargo CA; Sparks JA
    Arthritis Res Ther; 2019 Nov; 21(1):246. PubMed ID: 31753003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical.
    Boeters DM; Mangnus L; Ajeganova S; Lindqvist E; Svensson B; Toes REM; Trouw LA; Huizinga TWJ; Berenbaum F; Morel J; Rantapää-Dahlqvist S; van der Helm-van Mil AHM
    Arthritis Res Ther; 2017 May; 19(1):115. PubMed ID: 28569212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Subclinical Lung Involvement in ACPA-Positive Subjects through Functional Assessment and Serum Biomarkers.
    Lucchino B; Di Paolo M; Gioia C; Vomero M; Diacinti D; Mollica C; Alessandri C; Diacinti D; Palange P; Di Franco M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients.
    Meyer P; Ally M; Hodkinson B; Anderson R; Tikly M
    Afr Health Sci; 2018 Jun; 18(2):295-303. PubMed ID: 30602956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis.
    Yang JA; Lee JS; Park JK; Lee EB; Song YW; Lee EY
    Korean J Intern Med; 2019 Mar; 34(2):434-441. PubMed ID: 28352064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis.
    Lingampalli N; Sokolove J; Lahey LJ; Edison JD; Gilliland WR; Holers VM; Deane KD; Robinson WH
    Clin Immunol; 2018 Oct; 195():119-126. PubMed ID: 29842946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia.
    Ten Brinck RM; van Steenbergen HW; van Delft MAM; Verheul MK; Toes REM; Trouw LA; van der Helm-van Mil AHM
    Rheumatology (Oxford); 2017 Dec; 56(12):2145-2153. PubMed ID: 28968865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
    Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
    Front Immunol; 2018; 9():876. PubMed ID: 29740454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cyclic citrullinated Peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis.
    Yin Y; Liang D; Zhao L; Li Y; Liu W; Ren Y; Li Y; Zeng X; Zhang F; Tang F; Shan G; Zhang X
    PLoS One; 2014; 9(4):e92449. PubMed ID: 24743261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain.
    Eloff E; Martinsson K; Ziegelasch M; Cedergren J; Reckner Å; Skogh T; Karlsson L; Ärlemalm A; Borggreven NV; Trouw LA; Kastbom A
    Scand J Rheumatol; 2021 May; 50(3):189-197. PubMed ID: 33243072
    [No Abstract]   [Full Text] [Related]  

  • 19. High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities.
    Salaffi F; Carotti M; Di Carlo M; Tardella M; Giovagnoni A
    Medicine (Baltimore); 2019 Sep; 98(38):e17088. PubMed ID: 31567944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum rheumatoid factor, anti-citrullinated protein antibodies and active rheumatoid arthritis disease are not associated with chronic periodontitis.
    Che Rahim MJ; Wan Mohamad WM; Saddki N; Taib H; Wan Abhamid WZ; Wong KK; Wan Ghazali WS
    Malays J Pathol; 2019 Dec; 41(3):267-272. PubMed ID: 31901911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.